Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
|Articles|December 16, 2010
Natto Pharma Secures EU Patents for Vitamin K and Heart Health
Vitamin K specialist Natto Pharma (Lysaker, Norway) announced on Wednesday that the company has successfully defended two EU patents for vitamin K1 and K2 in heart health. The first patent claims vitamin K's use for decalcification of blood vessels and the second claims its use in preventing age-related stiffening of arteries, the company reported.
Advertisement
Vitamin K specialist
The first patent claims vitamin K's use for decalcification of blood vessels and the second claims its use in preventing age-related stiffening of arteries, the company reported.
The news further bolsters Natto Pharma's presence in a vitamin K market that is receiving new attention thanks to increasing research on the nutrient's cardiovascular and bone health benefits. The company manufactures MenaQ7, a source of K2 that has been the subject of dozens of published studies on K2.
"The EPO approval and confirmation of these two patents represents a milestone for NattoPharma," said Natto Pharma CEO Peter Carlsson. "This will significantly strengthen NattoPharma's intellectual property rights and contribute to NattoPharma's competitive advantage and the ability to support our customers and partners in the marketing of MenaQ7 within the food supplement market as well as the functional food market."
Advertisement
Related to this article
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Session speakers at SupplySide Global 2026 covered consumer survey data, extraction methods, dosing, and claims for formulators working with functional mushrooms in beverages and foods.
Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Mit Metah, executive vice president at Unibar, about the launch of ElaQuin and how it connects to Bellaneo, Unibar’s melanin-inhibiting cosmeceutical ingredient.
At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
2
Formulating With Functional Mushrooms: What Extraction and Dose Mean for Beverages and Foods
3
Vitaquest's 2027 Consumer Trends Forecast
4
SupplySide Global Panel Weighs Purpose, Transparency, and Affordability in Nutrition
5